Quercis Pharma ^None

Quercis Pharma is a biopharmaceutical company based in Zug, Switzerland that focuses on developing innovative and safe medicine for patients with orphan diseases. Their current development pipeline includes late-stage clinical studies that aim to prevent VTE in cancer patients, as well as targeting other diseases associated with thrombotic events such as SCD, Ebola, and COVID-19. Their lead drug candidate is an antithrombotic with a lower risk of adverse events than existing treatments. The company was founded in 2019.